InsiderClue
Insiders · Profile

Alam Kamran

CHIEF FINANCIAL OFFICER at Taysha Gene Therapies. Filing since 18 Aug 2021. CIK 0001793412

Company
Date
Role
Action
Shares
Amount
Of holding
TSHA Taysha Gene Therapies, Inc.
4 Feb 2026
CHIEF FINANCIAL OFFICER
Sold at will
1,655
$7.48K
0.1%
TSHA Taysha Gene Therapies, Inc.
26 Jan 2026
CHIEF FINANCIAL OFFICER
Sold at will
23,849
$109.94K
1.6%
TSHA Taysha Gene Therapies, Inc.
23 Jan 2026
CHIEF FINANCIAL OFFICER
Sold at will
78,968
$375.10K
5.1%
TSHA Taysha Gene Therapies, Inc.
21 Aug 2025
CHIEF FINANCIAL OFFICER
Sold at will
54,491
$155.30K
4.4%
TSHA Taysha Gene Therapies, Inc.
24 Aug 2023
Chief Financial Officer
Sold on a plan
33,000
$76.89K
11.3%
TSHA Taysha Gene Therapies, Inc.
23 Aug 2022
Chief Financial Officer
Sold, plan not stated
3,325
$11.54K
1.2%
TSHA Taysha Gene Therapies, Inc.
22 Aug 2022
Chief Financial Officer
Sold, plan not stated
9,717
$34.01K
3.5%
TSHA Taysha Gene Therapies, Inc.
19 Aug 2022
Chief Financial Officer
Sold, plan not stated
11,482
$43.06K
4.0%
TSHA Taysha Gene Therapies, Inc.
18 Aug 2022
Chief Financial Officer
Sold, plan not stated
7,476
$28.93K
2.5%
TSHA Taysha Gene Therapies, Inc.
20 Aug 2021
Chief Financial Officer
Sold, plan not stated
11,840
$198.65K
3.8%
TSHA Taysha Gene Therapies, Inc.
19 Aug 2021
Chief Financial Officer
Sold, plan not stated
9,967
$164.17K
3.1%
TSHA Taysha Gene Therapies, Inc.
18 Aug 2021
Chief Financial Officer
Sold, plan not stated
11,193
$194.20K
3.4%
12 decisions on file.